Study Protocol: insulin and its role in cancer
2007

The Role of Insulin in Cancer

Sample size: 800 publication Evidence: moderate

Author Information

Author(s): Harish K, Dharmalingam M, Himanshu M

Primary Institution: M. S. Ramaiah Medical College & Hospital, Bangalore, India

Hypothesis

Hyperinsulinaemia increases bioactivity of free IGF-1, which may contribute to the process of carcinogenesis.

Conclusion

The study aims to investigate the relationship between insulin resistance and IGF-1 levels in cancer patients, which could provide insights into cancer prevention and treatment strategies.

Supporting Evidence

  • High levels of insulin decrease the production of IGF-1 binding proteins, increasing free IGF-1 levels.
  • Insulin resistance is a component of metabolic syndrome, which may contribute to carcinogenesis.
  • The study focuses on cancer patients under age 50, where genetic factors may play a larger role.

Takeaway

This study is trying to find out if having too much insulin in the body can lead to cancer by looking at how insulin and a growth factor called IGF-1 are related.

Methodology

A two-group case-control study with 800 cancer patients and 200 healthy controls, measuring insulin resistance and IGF-1 levels.

Potential Biases

Potential biases may arise from the exclusion criteria and the reliance on self-reported health status.

Limitations

The precise role of IGF-1 and the extent of its influence on carcinogenesis cannot be determined in this study.

Participant Demographics

Participants include cancer patients under age 50 with solid epithelial cell tumors and healthy age- and sex-matched controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6823-7-10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication